Clinical Trial Update: Rocklatan vs Latanoprost Post-DSLT [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Rocklatan to latanoprost after DSLT is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• ROCKLATAN (Netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%)

Snippet

Sponsor: Eye Centers of Southeast Texas | Conditions: Glaucoma | Phase 4 | Status: NOT_YET_RECRUITING